Article

Comparison of the clinical and pathologic staging in patients undergoing radical cystectomy for bladder cancer.

Division of Urologic Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.
International braz j urol (Impact Factor: 0.96). 01/2007; 33(1):25-31; discussion 31-2. DOI: 10.1590/S1677-55382007000100005
Source: PubMed

ABSTRACT Radical cystectomy (RCx) is perhaps the most effective therapeutic approach for patients with muscle-invasive bladder cancer. Unfortunately, clinical staging is imprecise and the degree of understaging remains high. This study retrospectively evaluated patients undergoing RCx with regard to pathologic outcomes and degree of upstaging to better identify features that may lessen clinical understaging.
141 consecutive patients with urothelial bladder carcinoma who were candidates for RCx with curative intent were retrospectively evaluated. Preoperative clinical and pathological (i.e. TURBT) features were compared to pathological outcomes in the cystectomy specimen. Patients were also evaluated as to whether cystectomy was performed as their primary (n = 91) versus secondary (n = 50) treatment for recurrent/progressive disease. Date of cystectomy (<or= 5 years vs. > 5 years prior to study) was also analyzed.
Of the 141 patients, 54% were upstaged on operative pathology. The greatest degree of upstaging occurred in those with invasive disease preoperatively (cT2-T3). Twenty-six percent of all patients had node-positive disease, and 75% of cT3 patients were node-positive. Seven of 101 (7%) patients with clinical T2 disease were unresectable at the time of surgery. In the primary (vs. secondary) RCx group, more patients were upstaged (63% vs. 40%), non-organ confined (62% vs. 38%), and LN positive (31% vs. 20%). In the more modern cohort, the degree of upstaging was not improved.
Pathologic findings after RCx often do not correlate with preoperative staging. Over half of patients undergoing cystectomy are upstaged on their operative pathology. An improved understanding of the relative frequency of upstaging in cystectomy patients may have important implications in the decision-making and selection for neoadjuvant and adjuvant therapies for these high-risk populations.

Full-text

Available from: Culley C Carson, Aug 14, 2014
0 Followers
 · 
71 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Staging of bladder cancer is crucial for optimal management of the disease. However, clinical staging is not perfectly accurate. The aim of this study was to derive a simple scoring system in prediction of pathological advanced muscle-invasive bladder cancer (MIBC).
    Vojnosanitetski pregled. Military-medical and pharmaceutical review 09/2014; 71(9):851-7. DOI:10.2298/VSP130814040P · 0.27 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective To assess the utility of an extensive restaging examination performed after the completion of neoadjuvant chemotherapy (NAC) but before radical cystectomy (RC) in the management of patients with advanced bladder cancer. Methods We studied 62 patients who underwent NAC with the intent of proceeding to consolidative RC. A restaging examination, including endoscopic and bimanual examination, as well as cross-sectional imaging of the abdomen and pelvis, was performed after chemotherapy. The impact of restaging on clinical management was determined. In patients proceeding to RC, the degree of correlation between clinical stage (at diagnosis vs on restaging) and pathologic stage was determined. Results Restaging altered the treatment course in 6 patients (9.7%) in whom RC was not performed because of restaging findings. An additional 56 patients (90.3%) proceeded to RC. In these patients, compared with clinical stage at diagnosis, the postchemotherapy clinical stage correlated more strongly with pathologic stage (κ = 0.02 vs 0.17). On multivariate analysis, diagnostic clinical stage was not associated with pathologic stage (P = .85), whereas postchemotherapy clinical stage was strongly predictive of pathologic stage (P <.01). Conclusion An extensive restaging examination altered treatment strategy in a small, but clinically significant subset of patients treated with NAC for bladder cancer. Furthermore, restaging allowed for more accurate prediction of pathologic stage after RC, thereby improving assessment of patient prognosis. Consideration should be given to incorporating a restaging evaluation into the standard management paradigm for bladder cancer.
    Urology 08/2014; 84(2):358–364. DOI:10.1016/j.urology.2014.03.040 · 2.13 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Development of reliable medical decision support systems has been the subject of many studies among which Artificial Neural Networks (ANNs) gained increasing popularity and gave promising results. However, wider application of ANNs in clinical practice remains limited due to the lack of a standard and intuitive procedure for their configuration and evaluation which is traditionally a slow process depending on human experts. The principal contribution of this study is a novel procedure for obtaining ANN predictive models with high performances. In order to reach those considerations with minimal user effort, optimal configuration of ANN was performed automatically by Genetic Algorithms (GA). The only two user dependent tasks were selecting data (input and output variables) and evaluation of ANN threshold probability with respect to the Regret Theory (RT). The goal of the GA optimization was reaching the best prognostic performances relevant for clinicians: correctness, discrimination and calibration. After optimally configuring ANNs with respect to these criteria, the clinical usefulness was evaluated by the RT Decision Curve Analysis. The method is initially proposed for the prediction of advanced bladder cancer (BC) in patients undergoing radical cystectomy, due to the fact that it is clinically relevant problem with profound influence on health care. Testing on the data of the ten years cohort study, which included 183 evaluable patients, showed that soft max activation functions and good calibration were the most important for obtaining reliable BC predictive models for the given dataset. Extensive analysis and comparison with the solutions commonly used in literature showed that better prognostic performances were achieved while user-dependency was significantly reduced. It is concluded that presented procedure represents a suitable, robust and user-friendly framework with potential to have wide applications and influence in further development of health care decision support systems.
    Expert Systems with Applications 12/2014; 41(18):8092–8100. DOI:10.1016/j.eswa.2014.07.006 · 1.97 Impact Factor